transforming-growth-factor-beta and Scarlet-Fever

transforming-growth-factor-beta has been researched along with Scarlet-Fever* in 1 studies

Other Studies

1 other study(ies) available for transforming-growth-factor-beta and Scarlet-Fever

ArticleYear
Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease.
    Scandinavian journal of rheumatology, 1997, Volume: 26, Issue:4

    Kawasaki disease (KD) is one of the most important forms of vasculitis, and is characterized by the initiation of a proinflammatory cytokine cascade. To further characterize the immunological profile of KD, we measured the serum levels of transforming growth factor-beta 1 (TGF-beta 1) as a regulatory cytokine. We determined the concentration of TGF-beta 1 in the sera of the patients with KD, anaphylactoid purpura (AP), and scarlet fever, using a sandwich enzyme linked immunosorbent assay. The serum levels of TGF-beta 1 were decreased in patients with KD, but not in patients with AP or scarlet fever during the acute stage. We found an inverse correlation between TGF-beta 1 and soluble tumor necrosis factor (TNF) receptor levels in KD patients during the acute and subacute stage. Decreased levels of TGF-beta 1, in particular to suppress TNF alpha (TNF-alpha) production, is an important part of the regulatory system of increased TNF-alpha production which cause vasculitis.

    Topics: Adolescent; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Humans; IgA Vasculitis; Infant; Male; Mucocutaneous Lymph Node Syndrome; Receptors, Tumor Necrosis Factor; Scarlet Fever; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

1997